Time To Progression

What Time To Progression Means

Time to Progression, often called TTP, is a way to measure how long a person with cancer lives without the disease getting worse after diagnosis or starting treatment. "Progression" means the cancer grows, spreads to new areas, or new tumors appear. Doctors usually detect progression through imaging tests like CT scans, MRIs, or ultrasounds, or by measuring tumor markers in the blood. TTP counts the time from diagnosis or treatment start until the cancer shows signs of worsening.

Why Time To Progression Matters in Cancer Care

TTP helps doctors and patients understand how well a treatment is controlling the cancer. In clinical trials, it is used to compare new treatments to standard ones by seeing which keeps the cancer stable longer. This information can guide treatment choices and help set expectations. Unlike overall survival, which counts all causes of death, TTP focuses specifically on cancer progression. This can provide earlier insight into treatment benefits, as progression often happens before death.

What Patients Might See or Hear About TTP

Patients may hear about TTP during discussions about treatment options, clinical trial results, or in medical reports. For example, a doctor might say a new drug improves TTP by delaying cancer growth. Sometimes TTP is mentioned alongside related terms like progression-free survival (PFS) or disease-free survival, which have similar but slightly different meanings. Understanding these differences can help patients better interpret what the numbers mean for their care.

Common Confusions and Related Terms

TTP is closely related to progression-free survival (PFS), but they are not exactly the same. TTP usually does not count patients who die from causes other than cancer progression, while PFS includes both progression and death as events. This difference can affect how results are reported and interpreted. Also, "disease-free survival" refers to the time after treatment when no cancer is detectable, which is different from TTP where cancer is present but stable. Comparing wording in reports or studies helps avoid confusion.

How to Use This Information and Next Steps